Li Ren Kong

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Zhihao Lü, Junye Wang, Yongqian Shu et al. · BMJ · 2022 · 480 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence

Moriah H. Nissan, Christine A. Pratilas, Alexis M. Jones et al. · Cancer Research · 2014 · 310 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer

Shuanghu Yuan, Xindong Sun, Minghuan Li et al. · American Journal of Clinical Oncology · 2007 · 256 citations

Medicine, Oncology, Chemotherapy +4

miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1

Edward Lin, Li Ren Kong, Yi Luan · Journal of Biological Chemistry · 2009 · 243 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +15

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Andrea L.A. Wong, Ross A. Soo, Daniel S.W. Tan et al. · Annals of Oncology · 2015 · 170 citations

Medicine, Oncology, Pharmacology +11